Szymkowski
David Szymkowski, Monrovia, CA US
Patent application number | Description | Published |
---|---|---|
20150239951 | Methods of Treating Neurological Diseases - The present disclosure is directed to a method of treating neurological disorder comprising peripheral administration to a patient in need thereof a DN-TNF polypeptide that inhibits the activity of soluble TNF- but not transmembrane TNF-α. | 08-27-2015 |
David Edmund Szymkowski, Monrovia, CA US
Patent application number | Description | Published |
---|---|---|
20100222272 | Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders - The invention relates to a pharmaceutical composition comprising a variant TNF-α protein that inhibits the activity of soluble TNF-α while substantially maintaining the activity of transmembrane TNF-α, a buffer, and a tonicity agent, wherein said composition has a pH from approximately 5.0 to 8.0. | 09-02-2010 |
Thomas J. Szymkowski, Farmington Hills, MI US
Patent application number | Description | Published |
---|---|---|
20140292283 | TECHNIQUES FOR ENHANCED BATTERY PACK RECHARGING - A method includes detecting that a battery pack requires charging and is currently operable for recharging. The method can identify a specific cell having a highest voltage in response to the detecting. The method can then recharge each cell of the battery pack to a predetermined voltage that is a sum of (i) a maximum open circuit voltage of the specific cell and (ii) a voltage based on a resistance of and a first current supplied to the specific cell. When a temperature of the specific cell is less than a predetermined temperature or an age of the specific cell is greater than a predetermined age, the method includes recharging each cell to the predetermined voltage at less than the first current when (i) a predetermined period has elapsed or (ii) a voltage of the specific cell is less than a voltage threshold. | 10-02-2014 |